Advertisement
Screener

Filana Therapeutics, Inc. (FLNA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Filana Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Filana Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $32.25M went out.
  • Fiscal year ended 2025-12-31: from investing, $581.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $239.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $33.07M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldOtherNot split outChange in cash
2025-12-31-$32.25M-$581.00K$90.00K-$33.07M
2024-12-31-$116.93M-$103.00K$918.00K$123.55M*$7.44M
2023-12-31-$82.03M-$414.00K$2.56M-$79.88M
2022-12-31-$77.51M-$2.71M$47.33M-$32.42M
2021-12-31-$30.20M-$22.21M$189.82M$2.52M*$139.93M
2020-12-31-$5.38M$360.00K$70.25M$5.20M*$70.42M
2019-12-31-$2.51M-$18.00K$5.81M*$3.27M
2018-12-31-$4.77M$14.10M$9.33M
2017-12-31-$8.24M$2.10M-$6.14M
2016-12-31-$12.23M-$2.17M-$14.68M
2015-12-31-$9.05M-$192.00K-$9.29M
2014-12-31-$9.55M$1.17M$379.00K-$8.00M
2013-12-31-$6.95M$5.66M$524.00K-$767.00K
2012-12-31-$7.17M$17.62M-$302.00K$57.00K-$33.99M*-$23.79M
2011-12-31-$260.00K$59.90M$9.04M-$339.00K$68.35M
2010-12-31-$143.00K$52.46M$2.08M$290.00K-$85.69M*-$31.00M
2009-12-31-$14.69M-$103.23M$564.00K-$9.00K-$117.36M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-03-31-$8.88M$0.00-$8.93M
2025-12-31-$9.75M*-$501.00K*$0.00*
2025-09-30-$6.22M*-$80.00K*$0.00*
2025-06-30-$4.95M*$0.00*$0.00*
2025-03-31-$11.34M$0.00$90.00K-$11.25M
2024-12-31-$61.27M*-$57.00K*$918.00K*
2024-09-30-$18.30M*-$17.00K*$0.00*
2024-06-30-$18.24M*-$29.00K*$0.00*$101.39M*
2024-03-31-$19.13M$0.00$0.00$22.16M*$3.03M
2023-12-31-$22.32M*-$41.00K*$1.14M*
2023-09-30-$26.53M*-$22.00K*$464.00K
2023-06-30-$19.92M*$6.00K*$889.00K
2023-03-31-$13.26M-$357.00K$64.00K-$13.55M
2022-12-31-$21.32M*$335.00K*$47.33M*
2022-09-30-$21.55M*-$1.16M*$136.00K*
2022-06-30-$11.11M*-$1.47M*$119.00K*
2022-03-31-$23.53M-$425.00K$211.00K-$23.74M
2021-12-31-$7.99M*-$100.00K*$0.00*
2021-09-30-$14.76M*-$22.04M*$0.00*
2021-06-30-$5.14M*$0.00*$1.27M*
2021-03-31-$2.31M$189.82M$1.17M*$188.69M
2020-12-31-$1.18M*$0.00*$0.00*$70.61M*
2020-09-30-$2.17M*$0.00*$256.00K$735.00K*
2020-06-30-$842.00K*$260.00K*
2020-03-31-$1.19M$100.00K$3.61M*$2.52M
2019-12-31-$589.00K*$0.00*$5.87M*
2019-09-30-$730.00K*$0.00*
2019-06-30-$591.00K*$0.00*
2019-03-31-$604.00K-$18.00K-$682.00K
2018-12-31-$565.00K*-$72.00K*-$637.00K*
2018-09-30-$1.44M*$12.27M*$10.84M*
2018-06-30-$1.13M*$0.00*-$1.13M*
2018-03-31-$1.64M$1.90M$255.00K
2017-12-31-$1.44M*$0.00*-$1.44M*
2017-09-30-$2.15M*$0.00*-$2.15M*
2017-06-30-$3.20M*$0.00*-$3.20M*
2017-03-31-$1.45M$2.10M$649.00K
2016-12-31-$3.03M*-$1.54M*-$4.60M*
2016-09-30-$2.79M*-$625.00K*-$3.41M*
2016-06-30-$3.27M*$1.50M*-$1.99M*
2016-03-31-$3.14M-$1.50M-$4.68M
2015-12-31-$3.55M*$900.00K*-$2.69M*
2015-09-30-$2.41M*$51.00K*-$2.36M*
2015-06-30-$1.95M*$1.05M*-$897.00K*
2015-03-31-$1.15M-$2.19M-$3.34M
2014-12-31-$2.56M*$1.10M*$0.00*-$1.46M*
2014-09-30-$1.67M*-$851.00K*$0.00*-$2.52M*
2014-06-30-$2.59M*$1.00M*$313.00K*-$1.28M*
2014-03-31-$2.72M-$79.00K$66.00K-$2.74M
2013-12-31-$1.45M*$51.00K*$264.00K*-$1.14M*
2013-09-30-$1.82M*$1.00K*$0.00*-$1.82M*
2013-06-30-$1.80M*$1.50M*$254.00K*-$46.00K*
2013-03-31-$1.87M$4.10M$6.00K$2.24M
2012-12-31-$1.85M*-$2.60M*-$488.00K*-$33.94M*-$38.88M*
2012-09-30-$1.30M*$10.52M*$0.00*$9.22M*
2012-06-30-$1.95M*$7.00M*$5.24M*
2012-03-31-$2.07M$2.71M$635.00K
2011-12-31-$809.00K*$2.50M*$80.00K*$1.44M*
2011-09-30-$1.17M*$10.00M*$52.00K*$8.88M*
2011-06-30-$1.55M*$5.00M*$4.49M*$7.94M*
2011-03-31$3.27M$42.40M$4.42M$50.10M
2010-12-31-$3.34M*-$13.32M*-$84.83M*-$101.49M*
2010-09-30$3.43M*$35.94M*$154.00K*$39.52M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
BriaCell Therapeutics Corp. (BCTX)$0.037B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32